Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02035527
Title Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center, National Comprehensive Cancer Network
Age Groups: adult
Covered Countries USA

No variant requirements are available.